WCI

RI Related News

게시글 목록
No TItle Name Date Hit
730 KHNP Promoting Commercialization of Unused Tritium WCI Secretariat 2022/06/02 32
729 Convergent Therapeutics and IONETIX Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225) WCI Secretariat 2022/06/02 34
728 IONETIX and ATONCO Sign a Partnership Agreement to Fight Bladder Cancer WCI Secretariat 2022/06/02 34
727 IONETIX Partners with CIRA to Bring N-13 Ammonia to South Florida WCI Secretariat 2022/06/02 38
726 Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer WCI Secretariat 2022/06/02 25
725 Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients WCI Secretariat 2022/06/02 24
724 Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Cancer WCI Secretariat 2022/06/02 29
723 Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes WCI Secretariat 2022/06/02 32
722 Facility for Rare Isotope Beams opens its doors to Discovery WCI Secretariat 2022/06/02 36
721 Laurentis is Helping Meet Global Demands by Increasing He-3 Production WCI Secretariat 2022/06/02 37
720 CNNC Begins Production of carbon-14 at Qinshan reactor WCI Secretariat 2022/06/02 36
719 QSAM Biosciences Doses First Patient in its Clinical Trial for Cyclosam®, Radiopharmaceutical Drug Candidate for the Treatment of Bone Cancer WCI Secretariat 2022/06/02 33
718 POINT Biopharma Unveils FRONTIER: A Pan-Cancer FAP-α Targeted Clinical Program WCI Secretariat 2022/06/02 34
717 First European Union Patient Dosed with 177Lu-PNT2002 in the Phase 3 SPLASH Trial WCI Secretariat 2022/06/02 47
716 QSAM Biosciences Receives Japanese Patent for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam® WCI Secretariat 2022/05/04 66
First Prev 1 2 3 4 5 6 7 8 9 10 End (49 Page)

비밀글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.